EcoDrugPlus

Carbonic Anhydrase 7

Ensembl ID : ENSEEUG00000011058
Gene Symbol: CA7
1 External references
221 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSEEUG00000004896
Gene Symbol: CA9
1 External references
283 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSEEUG00000004283
Gene Symbol: CSNK1E
1 External references
265 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSEEUG00000013745
Gene Symbol: COMT
1 External references
277 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSEEUG00000007272
Gene Symbol: CTSK
1 External references
246 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSEEUG00000007124
Gene Symbol: CTSS
1 External references
270 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSEEUG00000009310
Gene Symbol: CDC7
1 External references
209 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSEEUG00000009776
Gene Symbol: CCKAR
1 External references
201 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSEEUG00000005515
Gene Symbol: CHRNA3
3 External references
202 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 4 Subunit

Ensembl ID : ENSEEUG00000015849
Gene Symbol: CHRNA4
1 External references
206 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 7 Subunit

Ensembl ID : ENSEEUG00000002093
Gene Symbol: CHRNA7
1 External references
249 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 2 Subunit

Ensembl ID : ENSEEUG00000004812
Gene Symbol: CHRNB2
1 External references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).